Similar levels of OVA257-264-specific CD8+ T cells were found after clodronate treatment in NAFLD mice suggesting that the tumor suppression was not through inducing more tumor-specific CD8+ T cells (Figure S2H). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatotic liver disease.